Emerging Therapeutic Targets and Experimental Drugs for the Treatment of NAFLD

The two main subsets of nonalcoholic fatty liver disease (NAFLD) include: (1) nonalcoholic fatty liver (NAFL), the more common and non-progressive subtype; and (2) nonalcoholic steatohepatitis (NASH), the less common subtype, which has the potential to progress to advanced liver damage. Current trea...

Descripción completa

Detalles Bibliográficos
Autores principales: Dibba, Pratima, Li, Andrew A., Perumpail, Brandon J., John, Nimy, Sallam, Sandy, Shah, Neha D., Kwong, Waiyee, Cholankeril, George, Kim, Donghee, Ahmed, Aijaz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6164020/
https://www.ncbi.nlm.nih.gov/pubmed/30235807
http://dx.doi.org/10.3390/diseases6030083

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6164020/
https://www.ncbi.nlm.nih.gov/pubmed/30235807
http://dx.doi.org/10.3390/diseases6030083

Ejemplares similares